
Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Prepared to a prescriber's order for one patient. Not FDA-approved.
Ivermectin is an antiparasitic medication, manufactured as oral tablets and topical products, that compounding pharmacies prepare in oral and topical forms on prescription.
Ivermectin is an antiparasitic drug in the avermectin family, originally derived from a soil bacterium. It binds chloride channels in the nerve and muscle cells of parasites, which paralyzes and kills them. The same channels are largely absent in mammals, and the drug binds the related human channels only weakly, so it has little effect on human nerve signaling. The manufactured oral tablet (Stromectol and generics) is FDA-approved for intestinal strongyloidiasis and for onchocerciasis, both caused by parasitic worms. Manufactured topical products are FDA-approved for head lice and for rosacea. The FDA has not authorized or approved ivermectin for preventing or treating COVID-19 in humans or animals. Prescribers may order ivermectin compounded when they want a strength, a liquid, or a topical base that is not manufactured, or a vehicle free of a specific excipient. Compounded ivermectin is not FDA-approved and requires a prescription.
The manufactured tablet carries no boxed warning. Its label warns that people heavily infected with the parasite Loa loa can develop a serious, sometimes fatal brain reaction, so tell your prescriber if you have lived in or traveled to West or Central Africa. The label also reports nervous system effects ranging from drowsiness to coma, rare severe skin reactions, liver enzyme changes, and eye reactions during onchocerciasis treatment. Common side effects include dizziness, nausea, diarrhea, itching and rash. Ivermectin has been reported to raise INR in people taking warfarin. Do not use it if you are allergic to it. The label states ivermectin should not be used during pregnancy and that it passes into breast milk in low amounts, so nursing mothers should weigh this with their prescriber. Never take animal ivermectin products. If side effects are severe or do not go away, talk to your prescriber or pharmacist.
Ivermectin is a semisynthetic macrocyclic lactone that binds glutamate-gated chloride channels in invertebrate nerve and muscle cells, causing hyperpolarization, paralysis and death of the parasite. It does not readily cross the human blood-brain barrier, and P-glycoprotein efflux limits CNS exposure, so P-gp inhibitors and P-gp genetic variants may raise neurotoxicity risk. Orally, peak plasma levels occur at about 4 hours, a high-fat meal increases bioavailability roughly 2.5-fold, half-life is about 18 hours, metabolism is primarily hepatic via CYP3A4 with minor CYP2D6 and CYP2E1 contributions, and excretion is mostly fecal. Stromectol tablets are labeled for intestinal (nondisseminated) strongyloidiasis and onchocerciasis; the label notes it does not kill adult Onchocerca volvulus. Manufactured topical ivermectin is approved for head lice and rosacea. MedlinePlus notes ivermectin is sometimes used for other roundworm infections, lice and scabies; prescribers may order compounded oral or topical ivermectin when no manufactured form suits. The FDA states it has not authorized or approved ivermectin for COVID-19 and its review of trial data does not demonstrate activity against it. Dosing and food timing per prescriber. Monitoring: pretreatment loiasis assessment with Loa loa exposure, repeat stool examinations after strongyloidiasis treatment, INR with warfarin. Not a controlled substance.
Shake the bottle well before every dose so the medication is evenly mixed. Measure with the oral syringe or dosing cup provided, using the milliliter markings, and never a kitchen spoon. Take it by mouth as your label directs. Rinse the syringe after use and recap the bottle.
Water-based suspensions are aqueous preparations. Under USP <795>, a preserved suspension usually carries a beyond-use date of up to 35 days at room temperature or refrigerated; an unpreserved one is refrigerated for up to 14 days. Oil-based suspensions are nonaqueous and may carry up to 90 days. Your label states storage and the beyond-use date. Keep out of reach of children and discard after that date.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice. Discuss your situation with a licensed healthcare provider.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Take orally